IHH Healthcare Bhd (IHHH.KL) priced its $2.1 billion initial public offering near the top of an indicative range.
Healthcare Health/Fitness
Illinois-based Drug Compounding Company Acquisition Stalls as Industry Attracts Scrutiny
The nationwide meningitis outbreak linked to a contaminated injectible steroid made by the New England Compounding Center has stalled the sale of an Illinois drug compounding company, the private equity backed Pharmedium Healthcare Corp., Dow Jones’ LBO Wire reported last week.
Deals of the Day -- Mergers and Acquisition
Reuters reports the merger and acquisition deals of the day. (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: Two former top aides to Canadian Prime Minister Stephen Harper said on Thursday he should approve a $15.
Venture Capitalists Slowing Down on Med tech Investments
Longer product development times, pressures to reduce cost and improve value are making it harder for young companies to get venture capital funding.
Forty Percent Rise in Angel Investments For Start-ups Last Year
According to a recently released report by CB Insights, angel investors are filling a geographic niche overlooked by venture capitalists.
Latest News
Sovereign wealth fund Kuwait Investment Authority (KIA), money manager BlackRock Inc (BLK.N), and twenty other cornerstone investors will buy around 62 percent of Malaysian firm IHH Healthcare's up-to-$2 billion IPO.
Ceptaris Therapeutics, Inc has raised $10 million through a Series D-1 private placement of preferred stock.
Sonic Healthcare Ltd, Australia's top pathology and radiology group, has agreed to buy some pathology assets from private equity-owned Healthscope for A$100 million ($100 million).
EveryMove Inc., an innovator in health rewards-based marketing and incentives, secured $2.6 million in Series A Financing
Total capital proceeds of recent investment round increased to $53 million. Celladon Corp. , a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced the receipt of additional capital proceeds from a second close of its recent venture financing to advance the Company's lead investigational product candidate MYDICAR® for the treatment of advanced heart failure.
The Paliwoda Group Announces its Health Tech Fund to Provide Seed-Stage Investments in Innovations That Lower Healthcare Costs.
Funding Directed to Expand Development of New Technology Platforms Throughout North America. Monteris Medical Inc. , a privately held medical device company dedicated to the development of innovative MRI guided, laser-based cancer treatments has secured $9 million in financing to support the continued commercialization of the company's NeuroBlate™ System (formerly AutoLITT®) within the North American neurosurgery market.
Abbott (NYSE: ABT) and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.
Creates Premier Workers’ Compensation Physical Medicine Network with Coverage in 50 States Align Networks, Inc. (“Align Networks” or “Align”), a leading provider of workers' compensation physical medicine programs, and Universal SmartComp (“USC”), a nationwide provider of physical medicine services, today announced that they have closed their previously announced merger.
